Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Denosumab versus bisphosphonates for the treatment of bone metastases from solid tumors: a systematic review

Published:2018-10-31 Issue:4 Volume:20 Page:487-499
ISSN:1618-7598
Container-title:The European Journal of Health Economics
language:en
Short-container-title:Eur J Health Econ

Author:

Matuoka Jessica Y.,Kahn James G.,Secoli Silvia R.

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s10198-018-1011-1.pdf

Reference62 articles.

1. Aapro, M., Saad, F., Costa, L.: Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases. Oncologist 15, 1147–1158 (2010)

2. Machado, M., Cruz, L.S., Tannus, G., Fonseca, M.: Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials. Clin. Ther. 31(5), 962–979 (2009)

3. Espinosa, J.C., Baamonde, A.G.A., Herrero, F.R., Martín, E.H.: SEOM guidelines for the treatment of bone metastases from solid tumours. Clin. Transl. Oncol. 14, 505–511 (2012)

4. Choudhury, K.B., Mallik, C., Sharma, S., Choudhury, D.B., Maiti, S., Roy, C.: A randomized conrolled trial to compare the efficacy of bisphosphonates in the management of painful bone metastasis. Indian J. Palliat. Care 17(3), 210–218 (2011)

5. Mundy, G.R.: Metastasis to bone: causes, consequences and therapeutic opportunities. Nature 2(8), 584–593 (2002)

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Biomarkers Related to Bone Metastasis of Breast Cancer;Advances in Clinical Medicine;2024

2. Denosumab versus pamidronate in the treatment of osteolytic bone metastases secondary to breast cancer: a multi-institutional analysis;Baylor University Medical Center Proceedings;2023-11-14

3. Bone-modifying agents for non–small-cell lung cancer patients with bone metastases during the era of immune checkpoint inhibitors: A narrative review;Seminars in Oncology;2023-06

4. Novel 99mTc labeled complexes with bisphosphonate isocyanide: Radiosynthesis and evaluation as potential bone-seeking agents;Bioorganic & Medicinal Chemistry Letters;2022-10

5. Research on the Economics of Cancer-Related Health Care: An Overview of the Review Literature;JNCI Monographs;2022-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3